← Back to Clinical Trials
Recruiting NCT06657430
A Study on the Preference of Risperidone Dosage Forms
Trial Parameters
Condition Schizophrenia
Sponsor Shanghai Mental Health Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-19
Completion 2025-02-28
Brief Summary
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Eligibility Criteria
Inclusion Criteria: * Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study. Exclusion Criteria: * Have difficulty reading and understanding Chinese or refuse to participate in the study.
Related Trials
NCT07467993
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults Wi
View Trial →
NCT06657430
A Study on the Preference of Risperidone Dosage Forms
View Trial →
NCT06376734
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
View Trial →